pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
IRL-201104
Eosinophilic Esophagitis
Revolo Biotherapeutics Ltd
Phase 2
IRX-101
Eye Infections
iRenix Medical Inc
Phase 2
IRX-4204
Parkinson's Disease
Io Therapeutics Inc
Preclinical
← prev
page 97 of 231
next →
131
Pain
89
Neurology
1
IS-101
InvisiMask
Coronavirus Disease 2019 (COVID-19)
InvisiShield Technologies Ltd
Phase 1
ISB-2001
Refractory Multiple Myeloma
$ABBV
AbbVie Inc.
Phase 1
ISM-3412
Solid Tumor
InSilico Medicine
Phase 1
ISM-6331
Malignant Mesothelioma
InSilico Medicine
Preclinical
ISM-9274
Solid Tumor
InSilico Medicine
Phase 2
ISN-001
Diabetic Foot Ulcers
Anterogen Co Ltd
ISOLYTE S PH 7.4
ISOLYTE S PH 7.4 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE)
no indication
B BRAUN
Phase 2
ISP-001
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Immusoft Corp
Preclinical
ISP-002
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Immusoft Corp
Preclinical
ISX9-CPC
Cardiomyopathy
IPS Heart Inc
Phase 1
ITI-1001
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
Phase 1
ITI-3000
Merkel Cell Carcinoma
Immunomic Therapeutics Inc
Preclinical
ITR-2401
Androgenic Alopecia
Solipharma LLC
IVABRADINE
IVABRADINE
no indication
ANNORA PHARMA
Phase 2
IVB-001
Metabolic Dysfunction-Associated Steatotic Liver Disease…
Invictus Therapeutics Ltd
Phase 1
IVB-003
Pancreatic Cancer
Invictus Therapeutics Ltd
Phase 2
IVMED-80
Keratoconus
$GKOS
GLAUKOS Corp
Phase 1
IVMED-85
Myopia
iVeena Delivery Systems Inc
IVRA
IVRA (MELPHALAN HCL)
no indication
APOTEX
Phase 2
IVS-3001
Epithelial Ovarian Cancer
Invectys SA
Preclinical
IVT-8086
Osteosarcoma
Innova Therapeutics Inc
Phase 2
IVW-1001
Keratoconjunctivitis Sicca (Dry Eye)
iView Therapeutics Inc
Preclinical
IVW-1802
Myopia
iView Therapeutics Inc
Preclinical
IXTV-100
Substance (Drug) Abuse
InterveXion Therapeutics LLC
Marketed
Iheezo
Iheezo (chloroprocaine [INN])
Local Anesthetic Effect
$HROW
HARROW, INC.
Phase 3
IkT-001
Pulmonary Arterial Hypertension
$IKT
Inhibikase Therapeutics, Inc.
Phase 2
ImMucin
ImMucin
Multiple Myeloma (Kahler Disease)
Vaxil Bio Therapeutics Ltd
